🇺🇸 FDA
Patent

US 10603296

Compositions and methods for diagnosis and treatment of neuromuscular disorders

granted A61KA61K31/20A61K31/417

Quick answer

US patent 10603296 (Compositions and methods for diagnosis and treatment of neuromuscular disorders) held by United States of America as represented by the Secretary of the Air Force expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/20, A61K31/417